๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
RATIONALE: Giving total-body irradiation and chemotherapy, such as thiotepa...
Status
Completed
Location
Childrens Hospital Los Angeles
Start Date
2005-06
Trial ID
NCT00376480
Combined antiretroviral therapy (ART) efficiently suppresses viral replicat...
Status
Unknown
Location
Beijing 302 Hospital of China
Start Date
2019-10-11
Trial ID
NCT04098770
Treatments Being Tested
This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized...
Status
Recruiting
Location
Nkarta Investigational Site
Start Date
2024-11-04
Trial ID
NCT06733935
Treatments Being Tested
The goal of this clinical research study is to learn if fludarabine, melpha...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2005-07
Trial ID
NCT00385788
Combination antiretroviral therapy (ART) effectively suppresses viral repli...
Status
Unknown
Location
Beijing 302 hospital
Start Date
2016-10
Trial ID
NCT02648516
Treatments Being Tested
The investigators hypothesize that flotetuzumab for relapsed AML following ...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2021-05-20
Trial ID
NCT04582864
Treatments Being Tested
This is an open-label, phase II study designed to evaluate the efficacy and...
Status
Terminated
Location
Bristol and Weston NHS foundation trust
Start Date
2022-08-15
Trial ID
NCT05358808
Treatments Being Tested
study evaluates EB-NK-301, an investigational off-the-shelf allogeneic CAR-...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07589530
Treatments Being Tested
Combined antiretroviral therapy (cART) efficiently suppress viral replicati...
Status
Completed
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02651376
Treatments Being Tested